Literature DB >> 21920940

The spinal muscular atrophy disease protein SMN is linked to the Rho-kinase pathway via profilin.

Anna Nölle1, Andre Zeug, Jeroen van Bergeijk, Lars Tönges, Ralf Gerhard, Hella Brinkmann, Sarah Al Rayes, Niko Hensel, Yvonne Schill, David Apkhazava, Sibylle Jablonka, Jana O'mer, Ratnesh Kumar Srivastav, Anne Baasner, Paul Lingor, Brunhilde Wirth, Evgeni Ponimaskin, Rainer Niedenthal, Claudia Grothe, Peter Claus.   

Abstract

Spinal muscular atrophy (SMA), a frequent neurodegenerative disease, is caused by reduced levels of functional survival of motoneuron (SMN) protein. SMN is involved in multiple pathways, including RNA metabolism and splicing as well as motoneuron development and function. Here we provide evidence for a major contribution of the Rho-kinase (ROCK) pathway in SMA pathogenesis. Using an in vivo protein interaction system based on SUMOylation of proteins, we found that SMN is directly interacting with profilin2a. Profilin2a binds to a stretch of proline residues in SMN, which is heavily impaired by a novel SMN2 missense mutation (S230L) derived from a SMA patient. In different SMA models, we identified differential phosphorylation of the ROCK-downstream targets cofilin, myosin-light chain phosphatase and profilin2a. We suggest that hyper-phosphorylation of profilin2a is the molecular link between SMN and the ROCK pathway repressing neurite outgrowth in neuronal cells. Finally, we found a neuron-specific increase in the F-/G-actin ratio that further support the role of actin dynamics in SMA pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21920940     DOI: 10.1093/hmg/ddr425

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  60 in total

Review 1.  Characteristics of circular RNAs generated by human Survival Motor Neuron genes.

Authors:  Eric W Ottesen; Ravindra N Singh
Journal:  Cell Signal       Date:  2020-06-15       Impact factor: 4.315

Review 2.  Profilin: many facets of a small protein.

Authors:  Rhonda J Davey; Pierre Dj Moens
Journal:  Biophys Rev       Date:  2020-07-13

Review 3.  Quantitative intensity-based FRET approaches--a comparative snapshot.

Authors:  André Zeug; Andrew Woehler; Erwin Neher; Evgeni G Ponimaskin
Journal:  Biophys J       Date:  2012-11-07       Impact factor: 4.033

Review 4.  Advances in therapeutic development for spinal muscular atrophy.

Authors:  Matthew D Howell; Natalia N Singh; Ravindra N Singh
Journal:  Future Med Chem       Date:  2014-06       Impact factor: 3.808

Review 5.  Advances in therapy for spinal muscular atrophy: promises and challenges.

Authors:  Ewout J N Groen; Kevin Talbot; Thomas H Gillingwater
Journal:  Nat Rev Neurol       Date:  2018-02-09       Impact factor: 42.937

Review 6.  Diverse role of survival motor neuron protein.

Authors:  Ravindra N Singh; Matthew D Howell; Eric W Ottesen; Natalia N Singh
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-15       Impact factor: 4.490

7.  Genome-wide analysis shows association of epigenetic changes in regulators of Rab and Rho GTPases with spinal muscular atrophy severity.

Authors:  Galina Y Zheleznyakova; Sarah Voisin; Anton V Kiselev; Markus Sällman Almén; Miguel J Xavier; Marianna A Maretina; Lyudmila I Tishchenko; Robert Fredriksson; Vladislav S Baranov; Helgi B Schiöth
Journal:  Eur J Hum Genet       Date:  2013-01-09       Impact factor: 4.246

8.  Genetic inhibition of JNK3 ameliorates spinal muscular atrophy.

Authors:  Naresh K Genabai; Saif Ahmad; Zhanying Zhang; Xiaoting Jiang; Cynthia A Gabaldon; Laxman Gangwani
Journal:  Hum Mol Genet       Date:  2015-09-30       Impact factor: 6.150

Review 9.  Profilin1 biology and its mutation, actin(g) in disease.

Authors:  Duah Alkam; Ezra Z Feldman; Awantika Singh; Mahmoud Kiaei
Journal:  Cell Mol Life Sci       Date:  2016-09-26       Impact factor: 9.261

10.  Temporal requirement for SMN in motoneuron development.

Authors:  Le T Hao; Phan Q Duy; James D Jontes; Marc Wolman; Michael Granato; Christine E Beattie
Journal:  Hum Mol Genet       Date:  2013-03-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.